LEADER 03780nam  2201093z- 450 
001 9910557134903321
005 20231214132836.0
035   $a(CKB)5400000000040704
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68453
035   $a(EXLCZ)995400000000040704
100   $a20202105d2021      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aOxidative Stress in Diabetic Retinopathy
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 electronic resource (322 p.)
311   $a3-0365-0448-6 
311   $a3-0365-0449-4 
330   $aThe combination of an increasing prevalence of diabetes and the aging of populations enables the appearance of a greater number of associated complications such as diabetic retinopathy. Diabetic retinopathy is the leading cause of preventable vision loss in working-age adults. The objective of this Special Issue is to highlight the existing evidence regarding the relationship between oxidative stress and low-grade chronic inflammation induced by hyperglycemia with the development and progression of diabetic retinopathy, with an emphasis on the importance of early diagnosis and the use of antioxidant and anti-inflammatory approaches to prevent or delay the harmful effects of diabetes on retinal tissue.
606   $aMedicine$2bicssc
610   $aeicosanoids
610   $aoxidative stress
610   $adiabetic retinopathy
610   $acyclooxygenase
610   $alipoxygenase
610   $aCytochrome P450
610   $aHDAC6
610   $atubastatin A
610   $aretinal endothelial cells
610   $aretinal endothelial cell senescence
610   $adb/db mice
610   $aCinnamomi Ramulus
610   $aPaeoniae Radix
610   $aCPA4-1
610   $ablood-retinal barrier
610   $aoccludin
610   $ahuman retina
610   $aepiretinal membrane
610   $ainternal limiting membrane
610   $avitreoretinal surgery
610   $amacular hole
610   $aproliferative diabetic retinopathy
610   $aantioxidants
610   $adiabetes mellitus
610   $afree radicals
610   $ahigh-mobility group box 1 (HMGB1)
610   $ainflammatory pathways
610   $anovel therapies
610   $adiabetic retinopathy (DR)
610   $ainflammation
610   $aangiogenesis
610   $aextracellular vesicles
610   $amiRNA
610   $abiomarkers
610   $aapoptosis
610   $afenofibrate
610   $athioredoxin
610   $ahyperglycemia
610   $aastaxanthin
610   $acarotenoid
610   $areactive oxygen species
610   $aphotoreceptor cells
610   $aPI3K
610   $aNrf2
610   $aeicosapentaenoic acid (EPA)
610   $adocosahexaenoic acid (DHA)
610   $aretinal pigment epithelium
610   $aantioxidant
610   $aascorbic acid
610   $aretinal disease
610   $avitamin D
610   $aGLP-1
610   $asuperoxide dismutase
610   $abiomarkers of diabetic retinopathy
610   $ametabolic memory
610   $atear film
610   $aaqueous humor
610   $avitreous humor
610   $amitochondria
610   $aredox
610   $aphotoreceptor
610   $aglycation
610   $aaging
610   $aglyoxalase
615  7$aMedicine
700   $aOrtega$b A?ngel  Luis$4edt$01294143
702   $aOrtega$b A?ngel  Luis$4oth
906   $aBOOK
912   $a9910557134903321
996   $aOxidative Stress in Diabetic Retinopathy$93022924
997   $aUNINA